In the Covid-19 vaccination race the U.S. is proving to be a formidable competitor. The U.S. is vaccinating at a faster pace than any member of the E.U., and three times the E.U. average. Getting shots into the arms of often vaccine-hesitant E.U. resid…
Thanks to vaccines, polio prevalence has been reduced to a small sliver of what it once was. What takeaways from the eradication effort can we apply to our attempts to vaccinate against Covid-19?
Surgical masks are made primarily of polypropylene which releases a host of toxic chemicals when burned.
Reports from Italy of a spike in Covid-19 cases among the very young are a potential bellwether of what may happen in the US now that new variants are circulating more widely.
Government officials assert that proof of Covid-19 vaccinations in the form of proper documentation will expedite a return to international travel. Experts have, however, expressed concerns about the logistics, but also the equity of a vaccine passport.
At the state level, novel payment models and methods for Medicaid prescription drug cost containment are gaining traction. In Tennessee’s Medicaid program, the closed formulary is becoming a reality. Other states may decide to follow Tennessee’s lead.
Were we to know about this variant future, perhaps we could have been prepared. As it turns out, one scientist, Dr. Li Lanjuan, and her colleagues at Zhejiang University provided that early warning.
The U.S. has never had a publicly funded, independent health technology assessment body to evaluate drugs, diagnostics, and devices, and provide recommendations on pricing and reimbursement. This may change as the Biden Administration considers creatin…
Mutations that allow the virus to evade our immune response, give the virus a greater chance of surviving inside our bodies. Combine that with a mutation that allows the virus to replicate more quickly and the virus now poses a very real and immediate …
The study, conducted by the Monoclonal Antibody Discovery Lab, among others, aimed to investigate the evolution of SARS-CoV-2 in the immune population.
